{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:13:56Z","timestamp":1793697236107,"version":"4.5.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T00:00:00Z","timestamp":1278374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1743-422x-7-146","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T18:18:50Z","timestamp":1278440330000},"source":"Crossref","is-referenced-by-count":94,"title":["A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice"],"prefix":"10.1186","volume":"7","author":[{"given":"Gunther","family":"Spohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary T","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron EE","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Pumpens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert DME","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"891_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","volume":"2","author":"GL Campbell","year":"2002","unstructured":"Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ: West Nile virus. Lancet Infect Dis 2002, 2: 519-529. 10.1016\/S1473-3099(02)00368-7","journal-title":"Lancet Infect Dis"},{"key":"891_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3201\/eid1108.050289b","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL: Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005, 11: 1174-1179.","journal-title":"Emerg Infect Dis"},{"key":"891_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20051970","volume":"203","author":"WG Glass","year":"2006","unstructured":"Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM: CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 2006, 203: 35-40. 10.1084\/jem.20051970","journal-title":"J Exp Med"},{"key":"891_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/524691","volume":"197","author":"JK Lim","year":"2008","unstructured":"Lim JK, Louie CY, Glaser C, Jean C, Johnson B, Johnson H, McDermott DH, Murphy PM: Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008, 197: 262-265. 10.1086\/524691","journal-title":"J Infect Dis"},{"key":"891_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/153036604773083004","volume":"4","author":"DR O'Leary","year":"2004","unstructured":"O'Leary DR, Marfin AA, Montgomery SP, Kipp AM, Lehman JA, Biggerstaff BJ, Elko VL, Collins PD, Jones JE, Campbell GL: The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004, 4: 61-70. 10.1089\/153036604773083004","journal-title":"Vector Borne Zoonotic Dis"},{"key":"891_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1086\/521911","volume":"45","author":"DJ Gubler","year":"2007","unstructured":"Gubler DJ: The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007, 45: 1039-1046. 10.1086\/521911","journal-title":"Clin Infect Dis"},{"key":"891_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/00365540600740553","volume":"39","author":"D Kaptoul","year":"2007","unstructured":"Kaptoul D, Viladrich PF, Domingo C, Niubo J, Martinez-Yelamos S, De Ory F, Tenorio A: West Nile virus in Spain: report of the first diagnosed case (in Spain) in a human with aseptic meningitis. Scand J Infect Dis 2007, 39: 70-71. 10.1080\/00365540600740553","journal-title":"Scand J Infect Dis"},{"key":"891_CR8","volume-title":"Euro Surveill","author":"G Rossini","year":"2008","unstructured":"Rossini G, Cavrini F, Pierro A, Macini P, Finarelli A, Po C, Peroni G, Di Caro A, Capobianchi M, Nicoletti L, et al.: First human case of West Nile virus neuroinvasive infection in Italy, September 2008 - case report. Euro Surveill 2008., 13:"},{"key":"891_CR9","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","volume":"78","author":"J Arroyo","year":"2004","unstructured":"Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP: ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 2004, 78: 12497-12507. 10.1128\/JVI.78.22.12497-12507.2004","journal-title":"J Virol"},{"key":"891_CR10","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1073\/pnas.0601932103","volume":"103","author":"TP Monath","year":"2006","unstructured":"Monath TP, Liu J, Kanesa-Thasan N, Myers GA, Nichols R, Deary A, McCarthy K, Johnson C, Ermak T, Shin S, et al.: A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci USA 2006, 103: 6694-6699. 10.1073\/pnas.0601932103","journal-title":"Proc Natl Acad Sci USA"},{"key":"891_CR11","doi-asserted-by":"crossref","unstructured":"Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J: Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine 28: 632-649. 10.1016\/j.vaccine.2009.09.098","DOI":"10.1016\/j.vaccine.2009.09.098"},{"key":"891_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","volume":"59","author":"JT Roehrig","year":"2003","unstructured":"Roehrig JT: Antigenic structure of flavivirus proteins. Adv Virus Res 2003, 59: 141-175. full_text","journal-title":"Adv Virus Res"},{"key":"891_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1074\/jbc.M506614200","volume":"281","author":"JW Lee","year":"2006","unstructured":"Lee JW, Chu JJ, Ng ML: Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J Biol Chem 2006, 281: 1352-1360. 10.1074\/jbc.M506614200","journal-title":"J Biol Chem"},{"key":"891_CR14","doi-asserted-by":"publisher","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","volume":"76","author":"DW Beasley","year":"2002","unstructured":"Beasley DW, Barrett AD: Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 2002, 76: 13097-13100. 10.1128\/JVI.76.24.13097-13100.2002","journal-title":"J Virol"},{"key":"891_CR15","doi-asserted-by":"publisher","first-page":"38755","DOI":"10.1074\/jbc.M402385200","volume":"279","author":"DE Volk","year":"2004","unstructured":"Volk DE, Beasley DW, Kallick DA, Holbrook MR, Barrett AD, Gorenstein DG: Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 2004, 279: 38755-38761. 10.1074\/jbc.M402385200","journal-title":"J Biol Chem"},{"key":"891_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature03956","volume":"437","author":"GE Nybakken","year":"2005","unstructured":"Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH: Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 2005, 437: 764-769. 10.1038\/nature03956","journal-title":"Nature"},{"key":"891_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virusres.2006.09.002","volume":"123","author":"KS Choi","year":"2007","unstructured":"Choi KS, Nah JJ, Ko YJ, Kim YJ, Joo YS: The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization. Virus res 2007, 123: 216-218. 10.1016\/j.virusres.2006.09.002","journal-title":"Virus res"},{"key":"891_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2005.02.020","volume":"336","author":"MD Sanchez","year":"2005","unstructured":"Sanchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, Doms RW: Characterization of neutralizing antibodies to West Nile virus. Virology 2005, 336: 70-82. 10.1016\/j.virol.2005.02.020","journal-title":"Virology"},{"key":"891_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, et al.: Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Medicine 2005, 11: 522-530. 10.1038\/nm1240","journal-title":"Nat Medicine"},{"key":"891_CR20","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","volume":"167","author":"T Wang","year":"2001","unstructured":"Wang T, Anderson JF, Magnarelli LA, Wong SJ, Koski RA, Fikrig E: Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol 2001, 167: 5273-5277.","journal-title":"J Immunol"},{"key":"891_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","volume":"26","author":"BE Martina","year":"2008","unstructured":"Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD: Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 2008, 26: 153-157. 10.1016\/j.vaccine.2007.10.055","journal-title":"Vaccine"},{"key":"891_CR22","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","volume":"23","author":"M Ledizet","year":"2005","unstructured":"Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA: A recombinant envelope protein vaccine against West Nile virus. Vaccine 2005, 23: 3915-3924. 10.1016\/j.vaccine.2005.03.006","journal-title":"Vaccine"},{"key":"891_CR23","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","volume":"178","author":"JH Chu","year":"2007","unstructured":"Chu JH, Chiang CC, Ng ML: Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J Immunol 2007, 178: 2699-2705.","journal-title":"J Immunol"},{"key":"891_CR24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1086\/517613","volume":"195","author":"WF McDonald","year":"2007","unstructured":"McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, et al.: A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 2007, 195: 1607-1617. 10.1086\/517613","journal-title":"J Infect Dis"},{"key":"891_CR25","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","volume":"178","author":"G Spohn","year":"2007","unstructured":"Spohn G, Guler R, Johansen P, Keller I, Jacobs M, Beck M, Rohner F, Bauer M, Dietmeier K, Kundig TM, et al.: A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis. J Immunol 2007, 178: 7450-7457.","journal-title":"J Immunol"},{"key":"891_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/eji.200737989","volume":"38","author":"G Spohn","year":"2008","unstructured":"Spohn G, Keller I, Beck M, Grest P, Jennings GT, Bachmann MF: Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur J Immunol 2008, 38: 877-887. 10.1002\/eji.200737989","journal-title":"Eur J Immunol"},{"key":"891_CR27","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.4049\/jimmunol.175.9.6211","volume":"175","author":"G Spohn","year":"2005","unstructured":"Spohn G, Schwarz K, Maurer P, Illges H, Rajasekaran N, Choi Y, Jennings GT, Bachmann MF: Protection against osteoporosis by active immunization with TRANCE\/RANKL displayed on virus-like particles. J Immunol 2005, 175: 6211-6218.","journal-title":"J Immunol"},{"key":"891_CR28","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/eji.200636658","volume":"36","author":"TA Rohn","year":"2006","unstructured":"Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF: Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 2006, 36: 2857-2867. 10.1002\/eji.200636658","journal-title":"Eur J Immunol"},{"key":"891_CR29","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1099\/0022-1317-83-6-1523","volume":"83","author":"J Klovins","year":"2002","unstructured":"Klovins J, Overbeek GP, van den Worm SH, Ackermann HW, van Duin J: Nucleotide sequence of a ssRNA phage from Acinetobacter: kinship to coliphages. J Gen Virol 2002, 83: 1523-1533.","journal-title":"J Gen Virol"},{"key":"891_CR30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jmb.2006.08.053","volume":"363","author":"SH van den Worm","year":"2006","unstructured":"van den Worm SH, Koning RI, Warmenhoven HJ, Koerten HK, van Duin J: Cryo electron microscopy reconstructions of the Leviviridae unveil the densest icosahedral RNA packing possible. J Mol Biol 2006, 363: 858-865. 10.1016\/j.jmb.2006.08.053","journal-title":"J Mol Biol"},{"key":"891_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0378-1119(93)90261-Z","volume":"137","author":"TM Kozlovska","year":"1993","unstructured":"Kozlovska TM, Cielens I, Dreilinna D, Dislers A, Baumanis V, Ose V, Pumpens P: Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli. Gene 1993, 137: 133-137. 10.1016\/0378-1119(93)90261-Z","journal-title":"Gene"},{"key":"891_CR32","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1016\/S0021-9258(19)39417-7","volume":"265","author":"DS Peabody","year":"1990","unstructured":"Peabody DS: Translational repression by bacteriophage MS2 coat protein expressed from a plasmid. A system for genetic analysis of a protein-RNA interaction. J Biol Chem 1990, 265: 5684-5689.","journal-title":"J Biol Chem"},{"issue":"3","key":"891_CR33","doi-asserted-by":"publisher","first-page":"e9809","DOI":"10.1371\/journal.pone.0009809","volume":"5","author":"AC Tissot","year":"2010","unstructured":"Tissot AC, Renhofa R, Schmitz N, Cielens I, Meijerink E, Ose V, Jennings GT, Saudan P, Pumpens P, Bachmann MF: Versatile Virus-Like Particle Carrier for Epitope Based Vaccines. PLOS One 2010,5(3):e9809. 10.1371\/journal.pone.0009809","journal-title":"PLOS One"},{"key":"891_CR34","doi-asserted-by":"crossref","unstructured":"Martina BEE, van den Doel P, Koraka P, van Amerongen G, Spohn G, Haagmans BL, Fouchier RAM, Osterhaus ADME, Rimmelzwaan GF: A recombinant influenza A expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus. PLOS One; in press.","DOI":"10.1371\/journal.pone.0018995"},{"key":"891_CR35","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1128\/JVI.79.12.7300-7310.2005","volume":"79","author":"CY Huang","year":"2005","unstructured":"Huang CY, Silengo SJ, Whiteman MC, Kinney RM: Chimeric dengue 2 PDK-53\/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. J Virol 2005, 79: 7300-7310. 10.1128\/JVI.79.12.7300-7310.2005","journal-title":"J Virol"},{"key":"891_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","volume":"225","author":"MS Diamond","year":"2008","unstructured":"Diamond MS, Pierson TC, Fremont DH: The structural immunology of antibody protection against West Nile virus. Immunol rev 2008, 225: 212-225. 10.1111\/j.1600-065X.2008.00676.x","journal-title":"Immunol rev"},{"key":"891_CR37","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.8248784","volume":"262","author":"MF Bachmann","year":"1993","unstructured":"Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM: The influence of antigen organization on B cell responsiveness. Science 1993, 262: 1448-1451. 10.1126\/science.8248784","journal-title":"Science"},{"key":"891_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/14760584.7.1.43","volume":"7","author":"G Spohn","year":"2008","unstructured":"Spohn G, Bachmann MF: Exploiting viral properties for the rational design of modern vaccines. Expert Rev Vaccines 2008, 7: 43-54. 10.1586\/14760584.7.1.43","journal-title":"Expert Rev Vaccines"},{"key":"891_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1515\/BC.2008.064","volume":"389","author":"GT Jennings","year":"2008","unstructured":"Jennings GT, Bachmann MF: The coming of age of virus-like particle vaccines. Biol Chem 2008, 389: 521-536. 10.1515\/BC.2008.064","journal-title":"Biol Chem"},{"key":"891_CR40","volume-title":"WO2007\/039552 A1: Interleukin-1 conjugates and uses thereof","author":"MF Bachmann","year":"2007","unstructured":"Bachmann MF, Spohn G: WO2007\/039552 A1: Interleukin-1 conjugates and uses thereof. 2007."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-7-146\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T22:25:20Z","timestamp":1635632720000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-146","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]},"article-number":"146"}}